Alexandre de Nonneville

22PUBLICATIONS
32CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 26, 2026
ESR1 Y537S Detected in a Brain Metastasis but Not in Plasma ctDNA in HR+/HER2-Low Metastatic Breast Cancer: A Case Report.

|Jul 29, 2025
Toxicity Profiles of Antibody-Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer.

Bérénice Collineau, Anthony Gonçalves, Marie Domon

|Oct 16, 2024
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.

Gilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet

|Jun 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.

Alexandre de Nonneville, Elsa Kalbacher, Francesco Cannone

|May 25, 2024
The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know?

Alexandre Giraudo, Renaud Sabatier, Frederique Rousseau

|Feb 08, 2024
Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.

Gilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen

Pageof 4

Frequent Collaborators

8 joint publications

François Bertucci

5 joint publications

Pascal Finetti

5 joint publications

Anthony Gonçalves

4 joint publications

Gilles Houvenaeghel